Cover Image

Liver cancers with stem/progenitor-cell features: a rare chemotherapy-sensitive malignancy

Primary liver tumors are a heterogeneous group of malignancies. Besides classical hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC), combined and intermediate forms of liver cancer exist and can express stem-cell markers like nuclear cell adhesion molecule (NCAM-1/CD56), c-kit (CD117) or ep...

Full description

Saved in:
Bibliographic Details
Main Authors: Köhler, Bruno Christian (Author) , Waldburger, Nina (Author) , Schlamp, Kai (Author) , Jäger, Dirk (Author) , Weiss, Karl Heinz (Author) , Schirmacher, Peter (Author) , Springfeld, Christoph (Author)
Format: Article (Journal)
Language:English
Published: 05 June 2017
In: OncoTarget
Year: 2017, Volume: 8, Issue: 35, Pages: 59991-59998
ISSN:1949-2553
DOI:10.18632/oncotarget.19000
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.18632/oncotarget.19000
Verlag, kostenfrei, Volltext: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601796/
Get full text
Author Notes:Bruno Christian Köhler, Nina Waldburger, Kai Schlamp, Dirk Jäger, Karl Heinz Weiss, Henning Schulze-Bergkamen, Peter Schirmacher and Christoph Springfeld
Description
Summary:Primary liver tumors are a heterogeneous group of malignancies. Besides classical hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC), combined and intermediate forms of liver cancer exist and can express stem-cell markers like nuclear cell adhesion molecule (NCAM-1/CD56), c-kit (CD117) or epithelial cell adhesion molecule (EpCAM) together with high proliferative activity. Liver tumors with progenitor-cell features are associated with an unfavorable prognosis, but the phenotype has not resulted in therapeutic consequences so far., We report three patients with liver cancers with stem/progenitor-cell features that responded exceptionally well to chemotherapy. These encouraging results indicate that the identification of liver cancer with stem/progenitor-cell phenotype in a patient´s tumor might justify an attempt to treat the patient with chemotherapy. Further case studies and finally clinical trials will be necessary to determine the optimal treatment for patients with this rare form of liver cancer.
Item Description:Gesehen am 09.10.2018
Physical Description:Online Resource
ISSN:1949-2553
DOI:10.18632/oncotarget.19000

Similar Items